background preloader


Facebook Twitter

המרכז המוביל לבדיקות גנטיות. אונקוטסט. Does Gene Testing Spur Healthier Habits? Maybe Not. Photo Would knowing you are at high genetic risk for developing a disease like diabetes motivate you to live a healthier life?

Does Gene Testing Spur Healthier Habits? Maybe Not

A new study suggests it wouldn’t. Researchers at Cambridge University provided written information about the risk factors, prevention, treatment and consequences of Type 2 diabetes to 569 healthy middle-aged men and women. Then they randomly assigned them to one of three groups. One group got only the written advice. The second received a “genetic risk score” based on methods used by genetic testing companies. Researchers interviewed them eight weeks later and found no differences between the groups in what they ate or how active they were. “The consumer-direct testing companies would have you believe that genetic information is more motivating in behavior change,” said the lead author, Job G.

Continue reading the main story. The Promise of Genetic Testing in Medicine - Room for Debate. Log In. רפואה גנומית משנה את פני הטיפול בסרטן. רפואה גנומית משנה את פני הטיפול בסרטן תארו לכם עולם שבו בדיקה אחת הייתה יכולה להטות את הכף לטובת טיפול יעיל יותר שנלחם בסרטן הספציפי של חולה.

רפואה גנומית משנה את פני הטיפול בסרטן

חוויות זה גנטי: מסתבר שהחוויות שאנחנו עוברים מעצבות את הדנ"א של ילדינו. Genetic Tests for a Heart Disorder Mistakenly Find Blacks at Risk. Photo Genetic tests for an inherited heart disorder are more likely to have incorrect results in black Americans than in whites, according to a new study that is likely to have implications for other minorities and other diseases, including .

Genetic Tests for a Heart Disorder Mistakenly Find Blacks at Risk

Mistakes have been made because earlier research linking genetic traits to illness did not include enough members of minority groups to identify differences between them and the majority white population or to draw conclusions about their risks of disease. The new study, published Wednesday in The , focused on — a thickening of the wall of the heart that can cause abnormal rhythms and sudden death. The condition often has no symptoms, but can cause young athletes to pass out or even die during the intense activity of their sport.

It can be caused by inherited mutations in one of 10 to 20 genes, and affects one in 500 people in the United States. The misdiagnosis can have big repercussions. Richard Resnick: Welcome to the genomic revolution. James Watson: How we discovered DNA. Tania Simoncelli: Should you be able to patent a human gene? BRCA1 and BRCA2: Cancer Risk and Genetic Testing Fact Sheet. Easton DF.

BRCA1 and BRCA2: Cancer Risk and Genetic Testing Fact Sheet

Population-Based Screening for BRCA1 and BRCA2:  2014 Lasker Award. Women ascertained in this way, and found to carry a mutation in BRCA1 or BRCA2, had very high cancer risks.

Population-Based Screening for BRCA1 and BRCA2:  2014 Lasker Award

For BRCA1 mutation carriers, the combined risk of developing either breast or ovarian cancer was 60% (±7%) by age 60 and 83% (±7%) by age 80. For BRCA2 mutation carriers, risk was 33% (±9%) by age 60 and 76% (±13%) by age 80. Furthermore, these risks were significantly higher, at every age, among women born more recently than among women born earlier, a birth cohort effect also seen in prior studies. This trend likely reflects increasing prevalence of nongenetic risk factors for breast cancer, including earlier age of menarche and later ages of childbearing, factors related to improved nutrition and education for women in modern society. Notably, 50% of families found to harbor BRCA1 or BRCA2 mutations had no history of breast or ovarian cancer that would have triggered clinical attention.

Online Mendelian Inheritance in Man (OMIM): A database of human genes, genetic diseases and disorders. This tutorial is a part of the tutorial group Human variations.

Online Mendelian Inheritance in Man (OMIM): A database of human genes, genetic diseases and disorders

You might find the other tutorials in the group interesting: GAD: Genetic Association Database: An archived database associating human genes and polymorphisms with diseases. Apolipoprotein E. Apolipoprotein E (APOE) is a class of apolipoprotein found in the chylomicron and Intermediate-density lipoprotein (IDLs) that is essential for the normal catabolism of triglyceride-rich lipoprotein constituents.[1] In peripheral tissues, APOE is primarily produced by the liver and macrophages, and mediates cholesterol metabolism in an isoform-dependent manner.

Apolipoprotein E

In the central nervous system, APOE is mainly produced by astrocytes, and transports cholesterol to neurons via APOE receptors, which are members of the low density lipoprotein receptor gene family.[2] This protein is involved in Alzheimer’s disease and cardiovascular disease.[3] Structure[edit] Gene[edit] Protein[edit] Early-onset Alzheimer's disease. Answer three questions and help us improve Wikipedia.

Early-onset Alzheimer's disease

Thanks for the feedback! We are using it to make Wikipedia even better! Early-onset Alzheimer's disease, also called early-onset Alzheimer's, or early-onset AD, is the term used for cases of Alzheimer's disease diagnosed before the age of 65. בדיקות סקר נשאות למחלות גנטיות. Figure 3 : Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy : Nature Reviews Neuroscience. Newly synthesized amyloid precursor protein (APP) traffics through the secretory pathway to the plasma membrane, where it is primarily cleaved by the -secretase in the non-amyloidogenic pathway to produce a minimally toxic peptide called P3.

Figure 3 : Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy : Nature Reviews Neuroscience

When APP is internalized through the clathrin-mediated pathway it is delivered to endosomes, where it is cleaved first by the. What-I-learned-About-Heart-Disease. First, I want to say that I am NOT a doctor.


I am a petroleum geologist that was stricken with heart disease in 2007 at a very young age of 48. I exercised 5 days a week, I followed the American Heart Assoc. "low fat" eat healthy grains diet, limited my saturated fat, and I didn't even eat a cholesterol rich egg for over 20 years and still had major blockages in my heart. The big question was: Why did I and more than 25% of Americans each year, either die of a heart attack or find out that they have coronary heart disease? Well, take some time and listen to my story... Alzheimer's Disease - Biology Educational Resource. Alzheimer’s Drug Discovery Foundation. Understanding APOE Everyone carries two copies of the APOE gene, which makes a protein called apolipoprotein E (ApoE). There are three different types of the APOE gene, called alleles: APOE (epsilon) e2, e3 and e4 (or just E2, E3 and E4).

Everyone has two copies of the gene so the combination determines your APOE “genotype”: either E2/E2, E2/E3, E2/E4, E3/E3, E3/E4, or E4/E4. The E2 allele is the rarest form of APOE and carrying even one copy appears to reduce the risk of developing Alzheimer’s while the APOE3 allele is the most common and doesn’t seem to influence the risk. The APOE4 allele, present in ~20% of the population, increases the risk for Alzheimer’s. חוקרים זיהו שלושה סוגים חדשים של סוכרת סוג 2. סוכרת סוג 2 – סוכרת מבוגרים – המתבטאת בליקוי חלקי בייצור הורמון האינסולין, הפכה בשנים האחרונות לתופעה רווחת במדינות העולם המערבי, על רקע העלייה במימדי ההשמנה. המחלה המורכבת, שמספר הישראלים הלוקים בה נאמד כיום בכ-600 אלף וצפוי להאמיר ל-2 מיליון עד שנת 2030, מערבת מנגנונים ביולוגיים רבים, ולראייה תרופות רבות המיועדות לחולי סוכרת סוג 2, שפועלות בדרכים שונות להורדת רמות הסוכר בדם בקרב החולים.

לאורך השנים גברה ההבנה בקרב רופאים ומדענים כי במחלת הסוכרת סוג 2 עשויים להיות מעורבים מגוון ביטויים גנטיים, וכי חולים שונים במחלה חשופים במידה שונה לסיבוכיה השונים, ובייחוד מחלות לב וכלי דם, קטיעות רגליים, עיוורון, נוירופתיה סוכרתית וכשל בתפקוד הכליות עד כדי הצורך בטיפולי דיאליזה. A blog about recombinant bovine growth hormone (rBGH) in today's biotechnological society.